ALK-Positive Anaplastic Large Cell Lymphoma in a Patient With Chronic Lymphocytic Leukemia

被引:6
作者
Liu, Ting [2 ]
He, Mai
Carlson, Diane L.
Hedvat, Cyrus
Teruya-Feldstein, Julie [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Immunohistochem Lab, Dept Pathol, New York, NY 10021 USA
[2] Univ Utah, Dept Pathol, Huntsman Canc Hosp, Salt Lake City, UT USA
关键词
composite; synchronous lymphoma; chronic lymphocytic leukemia; anaplastic large cell lymphoma; B-CELL; RICHTERS TRANSFORMATION; CLL; ASSOCIATION; DISEASE;
D O I
10.1177/1066896908324259
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This article reports the case of a 59-year-old patient with an 8-year history of chronic lymphocytic leukemia (CLL), prostate carcinoma, and squamous cell carcinoma who developed an ALK-positive anaplastic large cell lymphoma (ALCL). Lymph node and bone marrow biopsies showed 2 distinct morphologic populations: (a) the CLL component showing a diffuse monomorphous infiltrate of small lymphocytes with the typical immunophenotype showing positive CD20, CD5, CD23, and kappa light chain restriction and (b) the ALCL component showing large anaplastic pleomorphic cells positive for CD30, CD45, ALK, CD45Ro, CD4, and vimentin. Polymerase chain reaction performed on the lymph node for immunoglobulin heavy chain and T-cell receptor gamma and beta showed gene rearrangements after macrodissection of morphologically distinct populations, indicating confirmed genetically distinct populations. Despite intensive chemotherapy, the patient died. This case represents the rare occurrence of an ALK-positive ALCL developing in a patient with CLL.
引用
收藏
页码:424 / 428
页数:5
相关论文
共 50 条
[21]   ALK-positive anaplastic large cell lymphoma of the thoracic spine occurring in pregnancy: A case report [J].
Yang, Sen ;
Jiang, Wei-Min ;
Yang, Hui-Lin .
WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (18) :2857-2863
[22]   ALK-positive anaplastic large cell lymphoma of the thoracic spine occurring in pregnancy: A case report [J].
Sen Yang ;
Wei-Min Jiang ;
Hui-Lin Yang .
World Journal of Clinical Cases, 2019, (18) :2857-2863
[23]   Non-Coding RNA Networks in ALK-Positive Anaplastic-Large Cell Lymphoma [J].
Fuchs, Steffen ;
Naderi, Julian ;
Meggetto, Fabienne .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
[24]   Intravascular large B-cell lymphoma occurring 25 years after treatment of ALK-positive anaplastic large cell lymphoma [J].
McKelvie, Penelope A. ;
Wools, Christine ;
Roberts, Leslie ;
Cook, Mark .
LEUKEMIA & LYMPHOMA, 2013, 54 (12) :2745-2747
[25]   Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma [J].
Li, Chunmei ;
Takino, Hisashi ;
Eimoto, Tadaaki ;
Ishida, Takashi ;
Inagaki, Atsushi ;
Ueda, Ryuzo ;
Suzuki, Ritsuro ;
Yoshino, Tadashi ;
Nakagawa, Atsuko ;
Nakamura, Shigeo ;
Inagaki, Hiroshi .
MODERN PATHOLOGY, 2007, 20 (06) :648-655
[26]   NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma [J].
Haque, Moinul ;
Li, Jing ;
Huang, Yung-Hsing ;
Almowaled, Meaad ;
Barger, Carter J. ;
Karpf, Adam R. ;
Wang, Peng ;
Chen, Will ;
Turner, Suzanne D. ;
Lai, Raymond .
CANCERS, 2019, 11 (08)
[27]   ALK-positive anaplastic large cell lymphoma with multifocal bone involvements: a case report and review of the literature [J].
Yang, Yuan ;
Xie, Qibing ;
Liu, Yi ;
Chen, Yuehong ;
Yin, Geng .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03) :2745-2751
[28]   Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma [J].
Amr Fadl ;
Andrew L. Feldman .
Journal of Hematopathology, 2023, 16 :125-126
[29]   Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma [J].
Fadl, Amr ;
Feldman, Andrew L. .
JOURNAL OF HEMATOPATHOLOGY, 2023, 16 (02) :125-126
[30]   Drug approval: Crizotinib for relapsed or refractory, ALK-positive, systemic anaplastic large cell lymphoma in pediatrics [J].
Meurillon, Roxane ;
Leruste, Amaury .
BULLETIN DU CANCER, 2023, 110 (03) :250-251